Trials / Conditions / Lung Adenocarcinoma Metastatic
Lung Adenocarcinoma Metastatic
6 registered clinical trials studyying Lung Adenocarcinoma Metastatic — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | SBU-RESET: RElaxation, Stress Reduction and Epigenetics Trial in Cancer Survivors NCT07161713 | Barbara Nemesure | N/A |
| Recruiting | CT-95 in Advanced Cancers Associated With Mesothelin Expression NCT06756035 | Context Therapeutics Inc. | Phase 1 |
| Completed | Durvalumab (MEDI4736) in Frail and Elder Patients With Metastatic NSCLC (DURATION) NCT03345810 | AIO-Studien-gGmbH | Phase 2 |
| Completed | Fostering Efficacy of Anti - PD-1 - Treatment: Nivolumab Plus Radiotherapy in Advanced NSCLC NCT03044626 | AIO-Studien-gGmbH | Phase 2 |
| Unknown | A+C in Metastatic Lung Adenocarcinoma Cancer NCT02946359 | Chinese PLA General Hospital | Phase 2 |
| Completed | EGFRdelEx19 and KRAS Exon 2 Mutation Detection in EBUS-TBNA NCT02975752 | University Hospital, Essen | — |